NCT02718586

Completed

Serum Level of Myokines and Protein Energy Wasting, Inflamma...

Tungs' Taichung Metroharbour Hospital Source

Compare

Other study identifiers

Sponsor study identifier

104074

Study Type

observational

Actual enrollment (reported)

170

Locations

0 countries

Sites

N/A

Timeline

Study Start

March 2016

Actual (reported)

Primary Completion

December 2016

Actual (reported)

Study Completion

December 2016

Actual (reported)

Brief Summary

The aim is to test if serum level of myokines are associated with protein energy wasting, inflammation and atherosclerotic vascular disease among Taiwanese dialysis patients. Some novel myokines levels, anthropometric parameters, cardiovascular risk factors, and presence of endothelial dysfunction will be examined in 250 subjects. The distribution of some recently identified myokines such as irisin, myotatin etc levels will be studied and correlated markers of malnutrition, endothelial dysfunction, inflammation and insulin resistance. In the present study, the investigators will further follow and investigate whether serum myokines levels are associated with long-term mortality from all causes and from cardiovascular disease.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 170 participants
Study completion date: December 2016
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2016
Actual (reported)
First Submitted
March 4, 2016
Actual (reported)
First Posted
March 24, 2016
Actual (reported)
Primary Completion
December 2016
Actual (reported)
Study Completion
December 2016
Actual (reported)

Last Updated: February 17, 2017
Status Verified: February 2017
Last Update Submitted: February 15, 2017

Conditions

Protein-energy; Imbalance

Keywords

MyokinesProtein Energy WastingHemodialysis

Outcome Measures

Primary Outcomes (1)

Presence of protein energy wasting
According to the diagnostic criteria for PEW proposed by ISRNM
1 year

Eligibility Criteria

Age20 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

hemodialysis (HD) patients

You may qualify if:

Both sexes aged between 20-70 years.

Sponsors & Collaborators

Tungs' Taichung Metroharbour Hospital
Otherlead

Enrollment

170 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CROSSOVER
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Director

Study Record Dates

First Submitted

March 4, 2016

First Posted

March 24, 2016

Study Start

March 2016

Actual (reported)

NCT04854226

Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Macronutrient Composition to Improve Growth

Not ApplicableUnknown

Received stable hemodialysis at least 3 months.

Written informed consent.

You may not qualify if:

Patients with malignant disease, acute infectious disease, inflammatory disease (such as collagen disease), advanced liver disease, and those taking any type of immunosuppressive medication are excluded.

Contact the study team to confirm eligibility.

Primary Completion

December 2016

Actual (reported)

Study Completion

December 2016

Actual (reported)

Last Updated

February 17, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing: Will share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02718586
Data provider: ClinicalTrials.gov
Source updated: 2017-02-17
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:34 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record